期刊文献+

乳酸乳球菌NICE系统食品级分泌表达载体pRNV48的构建及铜绿假单胞菌融合外膜蛋白的表达 被引量:2

Construction of a Food-Grade NICE System Vector pRNV48 in Lactococcus lactis and the Expression of Fusion OprF/H from Pseudomonas aeruginosa
下载PDF
导出
摘要 乳酸菌NICE系统是目前较理想的可控制蛋白质生产的食品级诱导表达系统,而乳酸菌分泌表达异源蛋白比细胞质表达更优越。本研究将以pVE5524为模板PCR扩增的1.5 kbSPUsp45-NucA-CWAM6-t1t2基因克隆到食品级细胞内诱导表达载体pRNA48上,构建成食品级细胞壁锚定表达载体pRNV48,与宿主菌L.lactisNZ9000共同构成乳酸乳球菌食品级细胞壁锚定诱导表达系统。为检测该系统的功能,将铜绿假单胞菌融合外膜蛋白基因OprF/H克隆进pRNV48中,并检测了OprF/H的表达量和免疫原性。 The food - grade nisin - controlled expression (NICE) system of lactic acid bacteria (LAB) is the overproduction and inducible expression system. The heterologous proteins secreted out of Lactococcus lactis is better than cytoplasmic production. The 1.5kb SP Usp45 - NucA - CWA M6 - tlt2 gene from the plasmid pVE5524 was cloned into a food - grade cytoplasmic inducible expression vector pRNA48 and named as pRNV48 which was used to construct the L. lactis food -grade inducible cell wall anchored expression system together with the L. Lactis NZ9000. To validate the expression of heterologous in the recombinant vector, OprF/H, a fusion gene from outer membrane protein F and H of Pseudomonas aeruginosa, was cloned into pRNV48, and the cell wall anchored OprF/H and its immunogenesity were inspected.
出处 《江西农业大学学报》 CAS CSCD 北大核心 2006年第5期745-752,共8页 Acta Agriculturae Universitatis Jiangxiensis
基金 江西省自然科学基金资助项目(0330044)
关键词 乳酸乳球菌 食品级载体 NICE系统 OprF/H Lactococcus lactis food - grade vector NICE system OprF/H
  • 相关文献

参考文献25

  • 1Eric E,Richard L E E,Genevieve D,et al.Molecular characterization of a theta replication plasmid and its use for development of a two-component food grade cloning system for Lactococcus lactis[J].Appl Environ Microbiol,2001,67 (4):1700-1709.
  • 2Dieye Y,Usai S,Clier F,et al.Design of a protein-targeting system for lactic acid bacteria[J].J Bacteriol,2001,183:4157-4166.
  • 3张万山,陈燕,曹郁生.铜绿假单胞菌外膜蛋白OprF和OprH基因扩增、融合、克隆及原核表达[J].江西医学院学报,2004,44(2):5-9. 被引量:3
  • 4J 萨姆布鲁克,D W 拉塞尔.分子克隆实验指南[M].3版.北京:科学出版社,2003.
  • 5Wells J M.Improved cloning vectors and transformation procedure for lactococcus lactis[J].J Appl Bacteriology,1993(74):629-636.
  • 6Boucher I,Parrot M,Gaudreau H,et al.Novel food-grade plasmid vector based on melibiose fermentation for the genetic engineering lactococcus lactis[J].Appl Environ Microbiol,2002,68:6152-6161.
  • 7Ribeiro L A,Azevedo V,Le Loir Y,et al.Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis:a first step towards food-grade live vaccines against brucellosis[J].Appl Environ Microbiol,2002,68:910-916.
  • 8Piard J C,Hautefort I,Fischetti V A,et al.The M6 protein from Streptococcus pyogenes:cloning and expression of its emm6 structural gene and cell wall anchoring efficiency in various lactic acid bacteria[J].J Bacteriol,1997,179:3068-3072.
  • 9上海市医学化验所.临床免疫学检验[M].1版.上海科学技术出版社,1986.
  • 10Pugsley A P,Possot O.The general secretory pathway of Klebsiella oxytoca:no evidence for relocalization or assembly of pilin-like PulG protein into a multiprotein complex[J].Mol Microbiol 1993,10:665-674.

二级参考文献11

  • 1Hughes EE,Gilleland HE. Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to affords protection against P. aeruginosa infection in a murine acute pneumonia model[J]. Vaccine, 1995, (13):1750- 1753.
  • 2Gilleland HE,Gilleland LB, Fowler MR. Vaccine efficacies of elastase, exotoxin A, and outer membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model[J]. J Med Microbiol, 1992, (38) :79-86.
  • 3Staczek J,Gilleland HE,Gilleland LB,et al. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection[J]. Infect Immun, 1998,(66) ..3 990-3 994.
  • 4Specht BU,Knapp B, Muth G,et al. Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F (porin) and outer mimbrane protein I fusion proateins[J]. Infect lmmun, 1996,(63): 1855- 1862.
  • 5Matthews-Greet JM,Gilleland HF. Outer mimbrane protein F (porin) preparation of Pscudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model[J]. J Infect Dis, 1987, (155): 1282-1291.
  • 6Price BM, Galloway DR, Baker NR, et al. Protection against Pseudomonas acruginosa chronic lung infecrion in mice by genetic immunization against outer membrane protein F (OprF)of P. aeruginosa[J]. Infect Immun,2001, (69) :3510-3515.
  • 7Gabelsbcrger J,Knapp B, Hundt E,et al. Immunogenic efficacy of differently produced rccombinant vaccines candidates against Pscudomonas acruginosa infcctions[J]. J Biotechnol, 2000,29(83) :3-12.
  • 8Woodruff WA, Hancock RE. Construction and characterization of Pseudomonas aeruginosa protein F-deficient mutants after invitro and in vivo insertion mutagenesis of the cloned gene[J]. J Bacteriol, 1988,170(6):2592-2598.
  • 9Bell A, Hancock R. E. Outer membrane protein H1 of Pseudomonas aeruginosa: purification of the protein and cloning and nucleotide sequence of the gene[J]. J Bacteriol, 1989,171(6) :3211-3217.
  • 10Stover CK,Pham XQ,Erwin A. L,et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen[J]. Nature,2000,406(6799) :959-964.

共引文献3

同被引文献39

  • 1李华,陈陵霞,许瑞安.纤溶活性的药学测定方法研究[J].中国临床药理学与治疗学,2008,13(9):1066-1070. 被引量:6
  • 2邓长江,刘向勇,鲍晓明.分泌性表达人rPA毕赤酵母工程菌株的构建及发酵条件的初步优化[J].山东大学学报(理学版),2004,39(5):107-111. 被引量:3
  • 3徐波,曹郁生,陈燕,郭兴华.乳酸乳球菌食品级诱导表达系统的构建及异源蛋白的表达[J].微生物学报,2007,47(4):604-609. 被引量:17
  • 4Noble S, McTavish D. Reteplase:A review of its phar- macological properties and clinical efficacy in the man- agement of acute myocardial infaction [J]. Drugs, 1996, 52 (4) : 589-505.
  • 5Davidson S. New clot busters threaten Genentech's tPA [J]. Nature Biotechnology, 1997, 15 (5) :405.
  • 6Kohnert U, Rudolph R, Verheijen J H, et al. Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06. 022 . Protein Engineering, 1992,5 (1) : 93-100.
  • 7Ebert K M, Selgrath J P, DiTullio P, et al. Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: Generation of transgenic goats and analysis of expression [J]. Nature Biotechnology, 1991, 9: 835-838.
  • 8Luo X G, Tian W J, Ni M, et al. Soluble expression of active recombinant human tissue plasminogen activator derivative (K2S) in Escherichia coli[J]. Pharmaceutical Biology, 2011,49 (6) : 653-657.
  • 9Deogny L, Weidenbach A, Hampton J W. Improved fi- brin plate method for fibrinolytic activity measurements: Use of bentonite precipitation and agar solidification [J]. Clinica Chimica Acta, 1975,60 (1) : 85-89.
  • 10Bolotin A, Wincker P, Mauger S, et al. The complete genome sequence of the lactic acid bacterium Lactococ- cus lactis ssp. lactis IL1403[J]. Genome Research, 2001,11 (5) :731-753.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部